Skip to content

Investment Potential

“Sizable Upside Potential”: 5 Biotech Stocks Under $10 For Aggressive Investors

“These are five stocks for aggressive investors looking to get share count leverage on biotech companies that have sizable upside potential,” says the author of today’s article of the five biotech stocks he highlights – all of which are trading under the $10 level and are rated “Overweight” at Oppenheimer. For these five biotech stocks, CLICK HERE.

Which COVID Vaccine Stock Is Best For Which Type Of Investor?

Pfizer, BioNTech, Moderna, Johnson & Johnson, Novavax: Which COVID vaccine stock is the best pick for investors seeking strong growth? What about those looking for income? And how about value investors? The author of today’s article assesses which vaccine stock is best for which type of investor, depending on which factor is the most important to them. For more, CLICK… 

“Low-Risk Income Growth Potential”: 3 Energy Stocks To Boost Retirement Portfolios

For retirees looking for income streams, today’s article highlights a trio of energy stocks to consider. Not only does each of these stocks pay an above-average yield but, more importantly, the author notes that the dividends are low risk as the businesses in question all generate predictable cash flows, have strong balance sheets, can cover their current dividends with room… 

5 High-Yielding Funds For A Contrarian Move On Energy

The energy sector has had a rough year – and the five energy-focused closed-end funds highlighted in today’s article have gotten beaten up right along with it. For the contrarian investor, then, the author of today’s article advises that “if you think 2018 is going to be oil’s year and you want a big income stream while you wait for…